Table 3. Uni- and multivariate linear regression analysis of clinical and biochemical variables for higher AIP.
| Univariate | aMultivariate | |||
|---|---|---|---|---|
| β (95% CI) | P | β (95% CI) | P | |
| Age (per year) | 0.001 (-0.002, 0.001) | 0.47 | -0.001 (-0.002, 0.001) | 0.14 |
| Women (vs. men) | 0.001 (-0.036, 0.036) | 0.9 | 0.015 (-0.020, 0.050) | 0.40 |
| PD (vs. HD) | 0.046 (0.010, 0.082) | 0.01 | 0.057 (0.022, 0.093) | 0.002 |
| DM (vs. no) | 0.053 (0.017, 0.088) | 0.003 | 0.044 (0.008, 0.0794) | 0.02 |
| BMI (per kg/m2) | 0.024 (0.019, 0.029) | <0.001 | 0.024 (0.018, 0.029) | <0.001 |
| log hs-CRP (per mg/L) | 0.022 (0.001, 0.043) | 0.04 | 0.026 (0.004, 0.047) | 0.02 |
aAdjusted for age, sex, dialysis modality, DM, BMI, and log hs-CRP levels
Abbreviations: AIP, atherogenic index of plasma; BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; HD, hemodialysis; hs-CRP, high-sensitivity C-reactive protein; PD, peritoneal dialysis.